MOD-5014
- Generic Name
- MOD-5014
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
MOD-5014 is a long-acting carboxy-terminal peptide (CTP)-modified Factor IIa. It is being investigated for the treatment of hemophilia.
- Associated Conditions
- -
- Associated Therapies
- -
A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B
- First Posted Date
- 2015-04-16
- Last Posted Date
- 2021-05-20
- Lead Sponsor
- OPKO Health, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT02418793
- Locations
- 🇺🇸
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
🇺🇸City of Hope, Duarte, California, United States
🇺🇸Orthopaedic Hemophilia Treatment Center, Los Angeles, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath